Related references
Note: Only part of the references are listed.Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron
Juan Manuel Carreno et al.
NATURE (2022)
Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
Sandile Cele et al.
NATURE (2022)
Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
Yunlong Cao et al.
NATURE (2022)
Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2
Lihong Liu et al.
NATURE (2022)
SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons
Annika Roessler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants
Ruediger Gross et al.
EBIOMEDICINE (2022)
Heterologous ChAdOx1-S/BNT162b2 Vaccination: Neutralizing Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Chloe Dimeglio et al.
CLINICAL INFECTIOUS DISEASES (2022)
Neutralization Profile after Recovery from SARS-CoV-2 Omicron Infection
Annika Roessler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Comparative effectiveness and safety of homologous two-dose ChAdOx1 versus heterologous vaccination with ChAdOx1 and BNT162b2
Eduardo Hermosilla et al.
NATURE COMMUNICATIONS (2022)
Heterologous ChAdOx1/BNT162b2 vaccination induces stronger immune response than homologous ChAdOx1 vaccination: The pragmatic, multi-center, three-arm, partially randomized HEVACC trial
Zoltan Banki et al.
EBIOMEDICINE (2022)
COVID-19 vaccines: where we stand and challenges ahead
Guido Forni et al.
CELL DEATH AND DIFFERENTIATION (2021)
Immunogenicity and efficacy of heterologous ChAdOx1-BNT162b2 vaccination
Bruno Pozzetto et al.
NATURE (2021)
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
Merryn Voysey et al.
LANCET (2021)
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
David S. Khoury et al.
NATURE MEDICINE (2021)
Atypical thrombosis associated with VaxZevria® (AstraZeneca) vaccine: Data from the French Network of Regional Pharmacovigilance Centres
Valerie Gras-Champel et al.
THERAPIE (2021)
Real-world data shows increased reactogenicity in adults after heterologous compared to homologous prime-boost COVID-19 vaccination, March-June 2021, England
Annabel A. Powell et al.
EUROSURVEILLANCE (2021)
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial
Xinxue Liu et al.
LANCET (2021)
Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial
Alberto M. Borobia et al.
LANCET (2021)
Heterologous prime-boost vaccination with ChAdOx1 nCoV-19 and BNT162b2
Matthias Tenbusch et al.
LANCET INFECTIOUS DISEASES (2021)
Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination
Joana Barros-Martins et al.
NATURE MEDICINE (2021)
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers
Moriah Bergwerk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
COVID-19 Can immune responses predict which vaccines work best?
Jon Cohen
SCIENCE (2021)
Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study
David Hillus et al.
LANCET RESPIRATORY MEDICINE (2021)
COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses
Muhammad Adnan Shereen et al.
JOURNAL OF ADVANCED RESEARCH (2020)
Immunogenicity, effectiveness, and safety of measles vaccination in infants younger than 9 months: a systematic review and meta-analysis
Laura M. Nic Lochlainn et al.
LANCET INFECTIOUS DISEASES (2019)
GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables
Gordon Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
Alessandro Liberati et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)